BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: He YF, Ji CS, Hu B, Fan PS, Hu CL, Jiang FS, Chen J, Zhu L, Yao YW, Wang W. A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma. World J Gastroenterol 2013; 19(35): 5910-5916 [PMID: 24124338 DOI: 10.3748/wjg.v19.i35.5910]
URL: https://www.wjgnet.com/1007-9327/full/v19/i35/5910.htm
Number Citing Articles
1
Zhi-Qiang Wang, De-Shen Wang, Feng-Hua Wang, Chao Ren, Qiong Tan, Yu-Hong Li. Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II studyInvestigational New Drugs 2021; 39(2): 516 doi: 10.1007/s10637-020-01021-1
2
Chunyan Jia, Yunshuang Zhong, Xinzhong Zhang, Xiali Liao, Yamin Li, Bo Yang, Chuanzhu Gao. Host–guest inclusion systems of nedaplatin with cucurbit[7]uril for improved in vitro antitumour activityJournal of Inclusion Phenomena and Macrocyclic Chemistry 2020; 97(1-2): 99 doi: 10.1007/s10847-020-00988-x
3
Shiva Gholizadeh‐Ghaleh Aziz, Zahra Fardyazar, Maryam Pashaiasl. The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell lineMolecular Genetics & Genomic Medicine 2019; 7(7) doi: 10.1002/mgg3.726
4
Zhen-Qin Qiu, Kun Zhao. Expression of ERCC1, RRM1 and LRP in Non-small Cell Lung Cancers and their Influence on Chemotherapeutic Efficacy of Gemcitabine Concomitant with NedaplatinAsian Pacific Journal of Cancer Prevention 2014; 15(17): 7303 doi: 10.7314/APJCP.2014.15.17.7303
5
Ken Kato. Esophageal Squamous Cell Carcinoma2015; : 197 doi: 10.1007/978-4-431-54977-2_12
6
Jianming Xu, Yuxian Bai, Enxiao Li, Nong Xu, Danfeng Shi, Jing Qian. Efficacy and safety of chemotherapy regimens for first-line treatment of advanced esophageal squamous cell carcinoma in Asia: a systematic reviewExpert Review of Anticancer Therapy 2022; 22(9): 981 doi: 10.1080/14737140.2022.2110470
7
Ken Kato. Esophageal Squamous Cell Carcinoma2020; : 253 doi: 10.1007/978-981-15-4190-2_15
8
Yusuke Matsui, Takao Hiraki, Hideo Gobara, Hiroyasu Fujiwara, Toshihiro Iguchi, Yasuhiro Shirakawa, Toshiyoshi Fujiwara, Shinichi Toyooka, Susumu Kanazawa. Percutaneous Radiofrequency Ablation for Pulmonary Metastases from Esophageal Cancer: Retrospective Evaluation of 21 PatientsJournal of Vascular and Interventional Radiology 2014; 25(10): 1566 doi: 10.1016/j.jvir.2014.06.030
9
W Feng, X Xiaoyan, Y Xuan, L Xiangke, Y Zichang, Z Ran, W Liuxing, F Qingxia. Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxelCancer Gene Therapy 2015; 22(3): 115 doi: 10.1038/cgt.2014.74
10
Qingmin Guo, Rui Wang, Dongmei Jin, Zhengfang Yin, Bao Hu, Ruifeng Li, Dongyue Wu. Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysisTaiwanese Journal of Obstetrics and Gynecology 2022; 61(1): 15 doi: 10.1016/j.tjog.2021.11.006
11
Sherif Ashraf Fahmy, Fortuna Ponte, Mohamed K. Abd El-Rahman, Nino Russo, Emilia Sicilia, Tamer Shoeib. Investigation of the host-guest complexation between 4-sulfocalix[4]arene and nedaplatin for potential use in drug deliverySpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2018; 193: 528 doi: 10.1016/j.saa.2017.12.070
12
Jinghang Zhang, Jiateng Zhong, Jian Yu, Jinsong Li, Wenyu Di, Ping Lu, Xiaoyu Yang, Weixing Zhao, Xianwei Wang, Wei Su. Nestin expression involves invasiveness of esophageal carcinoma and its downregulation enhances paclitaxel sensitivity to esophageal carcinoma cell apoptosisOncotarget 2017; 8(39): 65056 doi: 10.18632/oncotarget.17774
13
LIFENG DANG, FENGBIAO WEN, YANG YANG, DONGLEI LIU, KAI WU, YU QI, XIANGNAN LI, JIA ZHAO, DENGYAN ZHU, CHUNYANG ZHANG, SONG ZHAO. Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cellsInternational Journal of Molecular Medicine 2014; 33(5): 1083 doi: 10.3892/ijmm.2014.1678
14
Chaoting Zhang, Heyilimu Palashati, Qin Tan, Wenjing Ku, Yu Miao, Hongchao Xiong, Zheming Lu. Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapyCarcinogenesis 2018; 39(11): 1389 doi: 10.1093/carcin/bgy116
15
Chong Zhang, Yang-Ling Li, Xu Weng, Li-Yan Li, Ming-Xian Zhou, Da-Yong Zhang, Neng-Ming Lin. Nedaplatin enhanced apoptotic effects of ABT-737 in human cancer cells via Mcl-1 inhibitionOncology Letters 2016; 12(5): 4195 doi: 10.3892/ol.2016.5151
16
Hongjin Wu, Sean Chen, Juehua Yu, Ying Li, Xiao-yan Zhang, Ling Yang, Hongfang Zhang, Qiang hou, Mingfeng Jiang, F. Charles Brunicardi, Charles Wang, Shixiu Wu. Single-cell Transcriptome Analyses Reveal Molecular Signals to Intrinsic and Acquired Paclitaxel Resistance in Esophageal Squamous Cancer CellsCancer Letters 2018; 420: 156 doi: 10.1016/j.canlet.2018.01.059